Includes pharmaceutical, herbal and street drugs by class and combination with molecular structure, links to additional information, indications, and approval dates.
FDA Drug News
- 7.27.2017 Abilify Maintena for Bipolar I disorder
- 6.20.2017 Mydayis for ADHD
- 4.11.2017 Ingrezza for tardive dyskinesia